TBPH

Theravance Biopharma Inc

Price:

9.44

USD

Volume:

243,048.00

Cayman Islands | Pharmaceuticals

-403.65 %

Upside

As of 2024-03-01, the Fair Value of Theravance Biopharma Inc (TBPH) is -28.66 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.44 USD, the upside of Theravance Biopharma Inc is -403.65%.

Note: valuation result may not be accurate due to the company's negative EPS.

9.44 USD

Stock Price

-28.66 USD

Fair Price

Peter Lynch's formula is:

TBPH Fair Value

= Earnings Growth Rate x TTM EPS
TBPH Fair Value

= 25.00 x -1.15
TBPH Fair Value

= -28.66
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |

Net income | -215.50 | -236.50 | -278.00 | -199.40 | 872.10 | -11.46 |

YoY growth | 24.49% | -9.74% | -17.55% | 28.27% | 537.36% | 112.57% |

Market Cap (mil) | 470.11 |

P/E | |

Forward P/E |

EPS | -1.15 |

Avg earnings growth rate | 112.57% |

TTM earnings | -57.10 |